Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic acid versus betamethasone facet joint infiltration for chronic low back pain
RBR-8qcgzxwPhase 4Not yet recruiting
- Sponsor
- Hospital São Domingos
- Start
- May 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic low back pain (CLBP) and spondylarthrosis (SpA) comparing Hyaluronic acid infiltration with Betamethasone infiltration (2 arms). Planned start May 2025; status: not yet recruiting.
02
Drugs
hyaluronic acidbetamethasone
03
Conditions
chronic low back pain (CLBP)spondylarthrosis (SpA)
Beyond the preview
Go deeper on RBR-8qcgzxw.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8qcgzxw.